These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 17722429)
1. Disease evolution of patients with mycosis fungoides--a report of 30 cases. Berlingeri-Ramos AC; De Jesús G; Sánchez JL; González JR P R Health Sci J; 2007 Jun; 26(2):151-4. PubMed ID: 17722429 [TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides--a review of the management of 28 patients and of the recent literature. Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715 [TBL] [Abstract][Full Text] [Related]
3. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308 [TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation. Kamarashev J; Theler B; Dummer R; Burg G Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880 [TBL] [Abstract][Full Text] [Related]
7. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671 [TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides associated with B-cell malignancies. Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178 [TBL] [Abstract][Full Text] [Related]
11. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224 [TBL] [Abstract][Full Text] [Related]
12. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore. Tan ES; Tang MB; Tan SH Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466 [TBL] [Abstract][Full Text] [Related]
13. Transformed mycosis fungoides: clinicopathological features and outcome. Barberio E; Thomas L; Skowron F; Balme B; Dalle S Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879 [TBL] [Abstract][Full Text] [Related]
14. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides]. Hagedorn M; Hasche E; Kober B; Sander CA Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995 [TBL] [Abstract][Full Text] [Related]
15. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases. Muniesa C; Estrach T; Pujol RM; Gallardo F; Garcia-Muret P; Climent J; Servitje O J Am Acad Dermatol; 2010 Mar; 62(3):418-26. PubMed ID: 20079954 [TBL] [Abstract][Full Text] [Related]
16. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999. Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306 [TBL] [Abstract][Full Text] [Related]
17. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG; Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564 [TBL] [Abstract][Full Text] [Related]
18. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma. Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274 [TBL] [Abstract][Full Text] [Related]
19. The head and neck manifestations of mycosis fungoides. Brennan JA Laryngoscope; 1995 May; 105(5 Pt 1):478-80. PubMed ID: 7760661 [TBL] [Abstract][Full Text] [Related]